This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Georgios Strimpakos in Muscular Dystrophy Treatment
Introduction
Georgios Strimpakos is a notable inventor based in Rome, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophy. With a total of 2 patents, his work focuses on innovative methods and compositions aimed at addressing muscle diseases.
Latest Patents
Strimpakos's latest patents include groundbreaking inventions that feature modified human transcription factors capable of increasing utrophin expression. These inventions utilize recombinant adeno-associated vectors for the delivery of the modified transcription factors, providing new methods for treating muscle diseases, including Duchenne's muscular dystrophy. Another patent involves recombinant adeno-associated vectors designed for delivering genes to both skeletal and cardiac muscle, along with methods for treating muscle defects associated with Duchenne's muscular dystrophy.
Career Highlights
Georgios Strimpakos is affiliated with the National Research Council (Consiglio Nazionale Delle Ricerche), where he continues to advance his research in muscular dystrophy. His work is characterized by a commitment to developing effective treatments for debilitating muscle diseases.
Collaborations
Strimpakos collaborates with esteemed colleagues, including Claudio Passananti and Cinzia Pisani, to further enhance the impact of his research. Their combined expertise contributes to the innovative approaches being developed in the field.
Conclusion
Georgios Strimpakos stands out as a pioneering inventor in the realm of muscular dystrophy treatment. His patents reflect a dedication to improving the lives of those affected by muscle diseases. Through his work, he continues to inspire advancements in medical research and innovation.